Biotech Startups

ekei labs develops precision measurement and visualization technology for epigenetic information to advance longevity and aging research. The company aims to create valuable datasets for machine learning algorithms and translate research outcomes into new health indicators for clinical use.

2 investors

electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions. The company operates in the bioelectronic medicine field and sells its products in markets including the US, UK, EU countries, Canada, Australia, New Zealand, and Saudi Arabia.

2 investors

Elemental Enzymes develops peptide and biochemical solutions to protect plants from disease and stress. The company serves agricultural markets by leveraging plant biology research to create plant protection products.

2 investors

Elevara Medicines is a clinical-stage biotech developing ELV001, a first-in-class once-daily oral CDK4/6 inhibitor that targets fibroblast-like synoviocytes as an add-on therapy for rheumatoid arthritis and other chronic inflammatory diseases. Its drug is designed to combine with existing DMARDs for patients who have an inadequate response to standard treatments like methotrexate and TNF inhibitors.

2 investors

Eleven Therapeutics develops mRNA therapeutics by combining synthetic chemistry with AI, using massively-parallel processes to map RNA chemical space and determine structure-activity relationships. The platform optimizes RNA molecules for safety, efficiency, and duration of effect.

2 investors

Elicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.

2 investors

Elicit Plant develops agricultural solutions that trigger plants' natural defenses to help field crops resist water stress and adapt to climate change. It targets the farming and food production sector with technology aimed at building more climate-resilient crops.

2 investors

Eliksa Therapeutics develops innovative treatments for rare diseases with unmet medical needs.

2 investors

Clinical-stage biotech developing next-generation polyene antifungals for life-threatening invasive fungal infections.

2 investors

Elm Biosciences is a clinical skincare company that develops dermatologist-formulated anti-aging products built around its patent-pending A3O antioxidant complex, sold directly to consumers. Its line includes topical treatments and daily supplements aimed at reducing visible signs of skin aging.

2 investors

Elo develops plant-based food ingredients and technologies to enhance nutritional value, taste, and climate resilience in everyday foods. The company works on solutions ranging from novel sweeteners to crop preservation to address food sustainability challenges.

2 investors

Elucidata is a company oriented around supporting scientific research, emphasizing making users' research more efficient and respecting the scientific method. The available page content does not describe its concrete products or offerings in detail.

2 investors

Elytron is a deeptech company that discovers and develops biological assets—using AI, multi-omics and functional testing—to turn microorganisms into industrial products. It serves industrial clients at various stages, from candidate discovery to deployment and process monitoring, with initial validation in agriculture and active operations in Argentina and Brazil.

2 investors

Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, including ecopipam, an investigational dopamine D1 receptor antagonist for pediatric Tourette syndrome. The company, created by Paragon Biosciences, advanced the asset through clinical development and was acquired by Teva Pharmaceutical Industries in 2026.

2 investors

Embion Tech develops PREMBION, a feed additive derived from hydrolyzed brewer's spent grains designed to improve animal gut performance and reduce antibiotic use in livestock farming. The product targets broiler poultry producers seeking antibiotic-free farming solutions while upcycling an agricultural byproduct.

2 investors

Emedgene provides genomic interpretation software that uses explainable AI and automation to prioritize, interpret, curate, and classify genetic variants from sequencing (WGS, WES, panels) and microarray data. It serves clinical and research genetics laboratories conducting rare disease research, hereditary risk assessment, carrier screening, and similar genetic disease testing workflows, and integrates with Illumina's DRAGEN secondary analysis.

2 investors

Emergent BioSolutions is a public health company that develops, manufactures, and supplies medical countermeasures for national security and preparedness, along with commercialized products addressing threats such as the opioid epidemic. It also provides in-house development and manufacturing support to biopharma innovators, governments, and non-governmental organizations.

2 investors

Emergo Therapeutics develops drugs designed to modulate inflammatory responses by reducing the production and secretion of inflammatory cytokines, targeting damaging symptoms across a range of diseases. Its pharmaceutical programs address acute and chronic conditions including flu/influenza-like illness and Long COVID, with clinical trials conducted in coordination with the FDA.

2 investors

eMolecules operates a digital chemical search platform and procurement service connecting researchers to over 83 million available chemical compounds from a global supplier network. The company serves drug discovery researchers and biopharmaceutical organizations seeking to reduce timelines and improve efficiencies in early-stage compound acquisition and management.

2 investors

Emotiv develops wearable EEG systems and software platforms that capture and analyze brain signals to support neuroscience research, brain-computer interfaces, and cognitive AI applications. The platform serves researchers, developers, and organizations seeking to understand brain function and enable human-computer interaction.

2 investors

Enanta Pharmaceuticals is a biotechnology company that discovers and develops small-molecule therapeutics using chemistry-based research to treat diseases with high unmet medical need. Its work has contributed to hepatitis C virus combination therapies, and its pipeline includes programs in areas such as respiratory syncytial virus (RSV).

2 investors

Enantios provides structural measurement services for molecules and proteins, as well as selling ROA (Raman Optical Activity) instruments for molecular characterization. The company serves researchers and companies working with chiral molecules, proteins, and antibodies.

2 investors

Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.

2 investors

Endless is an online workspace for content creators that brings AI-assisted tools such as chat, transcript generation, image and video creation, and a social radar into a single platform. It supports creative workflows like writing scripts, drafting post copy, and planning content weeks.

2 investors